1 Xenetic Biosciences Inc Receivables Turnover Ratio (XBIO), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xenetic Biosciences Inc   (NASDAQ: XBIO)
 

Xenetic Biosciences Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Xenetic Biosciences Inc Balance Sheet, in the second quarter 2026, company has not reported any Accounts receivable.
See Xenetic Biosciences Inc Balance Sheet

If we take a look into Healthcare sector 308 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2041 to 2115.

What is Receivable Turnover Ratio?
What is Xenetic Biosciences Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XBIO Receivables Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 11.99 % 36.01 % 18.11 % 67.19 % -18.79 %
Receivable Turnover Ratio (TTM) - - - - -
XBIO's Total Ranking # 2115 # 2041 # 1855 # 1848 # 2024
Accounts Receivable average collection period days - - - - -
Seq. Receivable Change - - - - -
Seq. Revenue Change -18.13 % 5.3 % -25.38 % 74.09 % -0.57 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 83
Healthcare Sector # 309
Overall Market # 2115

Receivable Turnover Ratio Statistics
High Average Low
0.49 0.21 0.02
(Sep 30 2025)   (Sep 30 2020)





XBIO Company Profile • Back to XBIO Efficiency Comparisons • Compare XBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Xenetic Biosciences Inc 's Accounts Receivable $ 0 Millions Visit XBIO's Balance sheet
Xenetic Biosciences Inc 's Sales TTM $ 3 Millions Visit XBIO's Income Statement
Sources of XBIO's Revenues Visit XBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
XBIO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
XBIO's Growth Rates XBIO's Roa XBIO's Inventory Turnover Ratio XBIO's Dividend Comparisons
XBIO's Profitability Ratios XBIO's Roi XBIO's Asset Turnover Ratio XBIO's Dividend Growth
XBIO's Valuation Ratios XBIO's Roe XBIO's Financial Strength Ratios XBIO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026

Date modified: 2026-09-05T06:55:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.